Monika Jankute1, Luke J Alderwick1, Stephan Noack2, Natacha Veerapen1, Jérôme Nigou3, Gurdyal S Besra1. 1. School of Biosciences, Institute of Microbiology and Infection, University of Birmingham , Edgbaston, B15 2TT Birmingham, United Kingdom. 2. Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH , Jülich D-52425, Germany. 3. Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS , 31077 Toulouse, France.
Abstract
Lipoarabinomannan (LAM) and arabinogalactan (AG) are the two major mycobacterial cell wall (lipo)polysaccharides, which contain a structurally similar arabinan domain that is highly branched and assembled in a stepwise fashion by variety of arabinofuranosyltransferases (ArafT). In addition to playing an essential role in mycobacterial physiology, LAM and its biochemical precursor lipomannan possess potent immunomodulatory activities that affect the host immune response. In the search of additional mycobacterial ArafTs that participate in the synthesis of the arabinan segment of LAM, we disrupted aftB (MSMEG_6400) in Mycobacterium smegmatis. The deletion of chromosomal aftB locus could only be achieved in the presence of a rescue plasmid carrying a functional copy of aftB, strongly suggesting that it is essential for the viability of M. smegmatis. Isolation and detailed structural characterization of a LAM molecule derived from the conditional mutant deficient in AftB revealed the absence of terminal β(1 → 2)-linked arabinofuranosyl residues. Furthermore, we demonstrated that truncated LAM displays proinflammatory activity, which is due to its ability to activate Toll-like receptor 2. All together, our results indicate that AftB is an essential mycobacterial ArafT that plays a role in the synthesis of the arabinan domain of LAM.
Lipoarabinomannan (LAM) and arabinogalactan (AG) are the two major mycobacterial cell wall (lipo)polysaccharides, which contain a structurally similar arabinan domain that is highly branched and assembled in a stepwise fashion by variety of arabinofuranosyltransferases (ArafT). In addition to playing an essential role in mycobacterial physiology, LAM and its biochemical precursor lipomannan possess potent immunomodulatory activities that affect the host immune response. In the search of additional mycobacterial ArafTs that participate in the synthesis of the arabinan segment of LAM, we disrupted aftB (MSMEG_6400) in Mycobacterium smegmatis. The deletion of chromosomal aftB locus could only be achieved in the presence of a rescue plasmid carrying a functional copy of aftB, strongly suggesting that it is essential for the viability of M. smegmatis. Isolation and detailed structural characterization of a LAM molecule derived from the conditional mutant deficient in AftB revealed the absence of terminal β(1 → 2)-linked arabinofuranosyl residues. Furthermore, we demonstrated that truncated LAM displays proinflammatory activity, which is due to its ability to activate Toll-like receptor 2. All together, our results indicate that AftB is an essential mycobacterial ArafT that plays a role in the synthesis of the arabinan domain of LAM.
Despite the
existence of treatments
for tuberculosis (TB), TB continues to represent a major healthcare
challenge, accounting for nearly 9 million new infections and over
1 million deaths each year.[1] Indeed, this
global health threat is escalating, given the variable efficacy of
the vaccine strain BCG, the increased susceptibility of HIV-infected
individuals to TB, and the increased prevalence of multi-drug-resistant
(MDR) and extensively drug-resistant (XDR) strains of Mycobacterium
tuberculosis, the causative agent of the disease.[1] As current treatments lose their efficacy, it
is vital that we address the increasing health burden of TB by replenishing
the drug pipeline with new drugs, drug targets, and improved treatment
regimes.The cell envelope of M. tuberculosis is unique
in that it contains a thick carbohydrate and lipid rich layer that
accounts for its inherent resistance to numerous drugs and contributes
to its persistence and virulence. This is due to the key cell envelope
structures, notably the mycolyl-arabinogalactan-peptidoglycan complex
(mAGP), lipomannan (LM), and lipoarabinomannan (LAM). The latter glycolipids,
in addition to their structural roles, exhibit potent immunomodulatory
activities and thus are probably important modulators of the host–pathogen
interactions during the course of infection.In mycobacteria,
LM is composed of approximately 20–25 α(1
→ 6) α-d-mannopyranosyl (Manp) residues connected in a linear fashion and are anchored to the
inner and outer membrane via their phosphatidyl-myo-inositol (PI) unit.[2,3] This mannose
core is further decorated with 7–10 singular α(1 →
2) Manp residues. The mature LM then serves as a
precursor to the formation of LAM where it is further glycosylated
by large arabinan domain consisting of approximately 55–70
Araf residues in a linear α(1 → 5)-d-Araf fashion with 3,5-α-d-Araf branches (Figure ).[4] Recent studies suggest that
this single arabinan chain is attached to the mannan core at the O-6 position of the mannosyl residue and not O-2 as previously reported.[5,6] Although, the arabinan
structure of LAM is more variable than that of AG, two types of highly
branched and conserved motifs remain. These are the tetra-arabinoside
(β-d-Araf(1 → 2)-α-d-Araf(1 → 5)-α-d-Araf(1 → 5)-α-d-Araf) and hexa-arabinoside ([β-d-Araf(1 → 2)-α-d-Araf]2-3,5-α-d-Araf(1 → 5)-α-d-Araf) motifs, both of which end with a characteristic
disaccharide unit (Araf-β(1 → 2)-Araf-α(1 →.).[4,5] The termini
of the arabinan domain are completed with the capping motifs that
are species dependent. The fast growers, such as M. smegmatis, are capped by phosphoinositide units (PILAM). The slow growers
including M. tuberculosis are capped with 2–3
mannose residues (Man-LAM), and some species, such as Mycobacterium
chelonae have uncapped LAM (AraLAM).[5,7,8] In addition, C. glutamicum, a closely related organism to M. tuberculosis and
a desired model organism to study mycobacterial AG and LM assembly,
produces LAM that lacks a highly branched arabinan domain and contains
single Araf residues attached to the mannan core
by AftE.[9] As a result, although the structure
of LAM has been fairly well described, understanding physiological
functions and biological activities of lipoglycans prove to be challenging.
Figure 1
Structural
representation of the wild type lipoarabinomannan and
the unknown arabinofuranosyltransferase investigated in this study.
Structural
representation of the wild type lipoarabinomannan and
the unknown arabinofuranosyltransferase investigated in this study.Targeting the enzymes responsible
for the synthesis and assembly
of the arabinan domains of AG and LAM continue to present opportunities
for new chemotherapeutics. Indeed, the front-line anti-TB drug ethambutol
targets the assembly of these vital cell wall structures by inhibiting
the embCAB operon.[10] Individual
genetic disruption of embA, embB, and embC in M. smegmatis revealed
that both EmbA and EmB are α(1 → 5) ArafT that play a key role in the synthesis of the arabinan domain of
AG, whereas EmbC is required exclusively for the elongation of the
arabinan domain of LAM.[10,11] Recently identified
α(1 → 6) ArafT, capable of utilizing
synthetic (1 → 6)-Manp disaccharide and trisaccaride
acceptors in vitro, was suggested to prime the mannan
core. However, further analysis is required to identify the enzyme
responsible.[6] Deletion studies in M. smegmatis identified ArafT with dual
function −AftC– that is responsible for the α-1,3-branching
of the linear arabinose polymers of AG and LAM.[12,13]In vitro assays using neoglycolipid acceptors and
cell-free extracts from M. smegmatis demonstrated
that AftD was able to add α(1 → 3) Araf residues to the linear α-1,5-linked acceptor, resulting in
branching of the linear arabinan. It was concluded that AftD participates
in the arabinan synthesis of both AG and LAM.[14] Finally, the branched arabinose motif of LAM is further modified
to either a tetra-arabinoside or a hexa-arabinoside motif by an unknown
β(1 → 2) ArafT.As several ArafT’s have a dual role and
are involved in the arabinan synthesis of both AG and LAM polysaccharides,
we investigated the potential role of AftB in LAM biosynthesis. Our
previous studies in Corynebacterium glutamicum identified
AftB as a nonessential ArafT responsible for the
terminal β(1 → 2) linkages at the nonreducing end of
the arabinan domain of AG.[15] However, the
disruption and essentiality of aftB in Mycobacterium species or its essential role in LAM biosynthesis has not been reported.
Herein, we demonstrate the essentiality of aftB in M. smegmatis using the conditional expression-specialized
transduction essentiality test (CESTET) and analyzed the structure
of LAM from the conditional M. smegmatisΔaftB::pMV306-aftB mutant. We have shown,
for the first time, that AftB has a dual function and is responsible
for β(1 → 2)-linked Araf incorporation
into LAM. Moreover, we have analyzed the immunological properties
of a LAM molecule isolated from the aftB conditional
mutant in order to shed the light on the structure–function
relationship between mycobacterial lipoglycans and host pattern recognition
receptors (PRRs), notably Toll-like receptor 2 (TLR2).
Results and Discussion
Construction
and Growth of the M. smegmatis aftB Conditional Mutant
Our earlier studies demonstrated that
the nonessential AftB from C. glutamicum (Cg-AftB)
adds the terminal β(1 → 2)-linked Araf residues to the arabinan domain of AG before its decoration with
mycolic acids.[15] In this study, we investigated
the potential role of AftB in the biosynthesis of LAM in M.
smegmatis. For this purpose, we constructed a knockout phage
phMSMEG6400 designed to replace the chromosomal M. smegmatis
aftB (Ms-aftB) with a hygromycin resistance
cassette (Figure a).
Several attempts to obtain a Ms-aftB null mutant
were unsuccessful, suggesting that Ms-aftB, unlike
its homologue in C. glutamicum, is an essential gene.[15] We then employed CESTET and generated a Ms-aftB conditional mutant by transducing a merodiploid M. smegmatis::pMV306-aftB strain containing
a second, inducible copy of aftB to yield M. smegmatisΔaftB::pMV306-aftB.[16] The correct replacement
of the native chromosomal copy of aftB with a hygromycin
cassette in the transductants was confirmed by Southern blot analysis
(Figure b). In order
to confirm aftB essentiality and to study the fate
of the mycobacterial cells depleted of AftB, we monitored the growth
of M. smegmatisΔaftB::pMV306-aftB in liquid medium in the presence and absence of acetamide
over 28 h (Figure c). Optical density (OD) measurements revealed normal growth kinetics
for the mutant strain grown in media containing acetamide. However,
cells cultured in the absence of inducer showed a decrease in OD after
16 h of growth and cell lysis after 28 h of incubation. This decrease
in OD correlated with a decrease in the number of CFUs (Figure c). Although, the aftB homologue in C. glutamicum has been reported to
be nonessential,[15] the failure to obtain
a aftB null mutant in the absence of second inducible
copy of aftB, coupled with the inability of M. smegmatis to grow in the media without acetamide, an
inducer that activates aftB expression, shows that
AftB is crucial for the viability of M. smegmatis. In addition, previous studies employing high density mutagenesis
studies suggest that Rv3805c in M. tuberculosis is
an essential gene.[17] It is reasonable to
conclude that aftB is essential for M. tuberculosis viability and therefore represents an attractive drug target.
Figure 2
Generation
of a conditional aftB mutant in M. smegmatis. (a) A map of the aftB region
in the parental M. smegmatis strain, its corresponding
region in the conditional M. smegmatisΔaftB::pMV306-aftB mutant and merodiploid
strain; res, resolvase site; hyg, hygromycin resistance gene from Streptomyces hygroscopicus; sacB, sucrose
counter-selectable gene from Bacillus subtilis. Digoxigenin-labeled
probes were derived from ∼1 kb upstream and downstream flanking
sequences that were used to construct the knockout plasmid and are
indicated by thick lines with square ends. SacI-digested bands expected
in a Southern blot are indicated in I, II, III, and *. (b) The Southern
blot of SacI-digested genomic DNA from the merodiploid and conditional aftB mutant with expected bands I, II, and III. The asterisk
(*) indicates a band appearing as a result of a second aftB copy integration into mycobacterial chromosome. Representative lanes
are from the same Southern blot and are grouped next to each other
for clarity. (c) Log CFU obtained from cultures of M. smegmatisΔaftB pMV306-aftB grown with
and without acetamide (Ac). Log10 CFU values were calculated
from different dilutions at different time points from a single experiment.
The images on the right show cultures after 28 h of growth in the
presence and absence of Ac. Results are mean ± SD from n = 3 colonies per strain and are from one representative
of two independent experiments.
Generation
of a conditional aftB mutant in M. smegmatis. (a) A map of the aftB region
in the parental M. smegmatis strain, its corresponding
region in the conditional M. smegmatisΔaftB::pMV306-aftB mutant and merodiploid
strain; res, resolvase site; hyg, hygromycin resistance gene from Streptomyces hygroscopicus; sacB, sucrose
counter-selectable gene from Bacillus subtilis. Digoxigenin-labeled
probes were derived from ∼1 kb upstream and downstream flanking
sequences that were used to construct the knockout plasmid and are
indicated by thick lines with square ends. SacI-digested bands expected
in a Southern blot are indicated in I, II, III, and *. (b) The Southern
blot of SacI-digested genomic DNA from the merodiploid and conditional aftB mutant with expected bands I, II, and III. The asterisk
(*) indicates a band appearing as a result of a second aftB copy integration into mycobacterial chromosome. Representative lanes
are from the same Southern blot and are grouped next to each other
for clarity. (c) Log CFU obtained from cultures of M. smegmatisΔaftB pMV306-aftB grown with
and without acetamide (Ac). Log10 CFU values were calculated
from different dilutions at different time points from a single experiment.
The images on the right show cultures after 28 h of growth in the
presence and absence of Ac. Results are mean ± SD from n = 3 colonies per strain and are from one representative
of two independent experiments.
Initial Characterization of Lipoglycans Extracted from the M. smegmatis aftB Conditional Mutant
Strains of M. smegmatis, M. smegmatis::pMV306-aftB, and conditional M. smegmatisΔaftB::pMV306-aftB mutant grown in the presence
and absence of acetamide were examined for their ability to synthesize
LAM. Exponentially growing cultures including M. smegmatisΔaftB::pMV306-aftB depleted
of AftB were labeled with [1, 2-14C]-glucose for 10 h followed
by lipoglycan extraction. [14C]-LAM and [14C]-LM
were profiled using SDS-PAGE analysis and the lipoglycans revealed
and quantified by phosphorimaging (Figure a). Extracts from all strains showed the
presence of [14C]-LAM and [14C]-LM (Figure a). Densitometry
analysis revealed no significant difference in lipoglycan profiles
extracted from different strains. Subsequently, [14C]-lipoglycans
were assessed for the reactivity with an anti-AraLAM (α-AraLAM)
monoclonal antibody (mAb, F30-5), which recognizes the terminal arabinan
branches of LAM.[18,19] All lipoglycan preparations reacted
with the antibody F30-5, with an exception of LAM isolated from the M. smegmatisΔaftB::pMV306-aftB depleted of AftB (Figure b). These results strongly indicate that
AftB is involved in the synthesis of the nonreducing end of arabinan
domain of LAM in M. smegmatis.
Figure 3
Lipoglycan profiles of M. smegmatis, M.
smegmatis pMV306-aftB, and M. smegmatisΔaftB pMV306-aftB strains
grown with and without acetamide. (a) Equivalent aliquots of [14C]-lipoglycans (20,000 cpm) were analyzed using SDS-PAGE
and visualized by phosphorimaging. The three major bands represented
by Ms-LAM, Ms-LM and Ms-PIMs are indicated. The protein molecular
weight standards are provided on the left for comparison. (b) Equivalent
aliquots (50 000 cpm) of [14C]-lipoglycans from
each strain were immunoblotted with α-AraLAM antibody F30-5
that recognizes the branches of the arabinan domain of LAM. The major
band represented by Ms-LAM is indicated. The protein molecular weight
standards are provided on the left for comparison.
Lipoglycan profiles of M. smegmatis, M.
smegmatis pMV306-aftB, and M. smegmatisΔaftB pMV306-aftB strains
grown with and without acetamide. (a) Equivalent aliquots of [14C]-lipoglycans (20,000 cpm) were analyzed using SDS-PAGE
and visualized by phosphorimaging. The three major bands represented
by Ms-LAM, Ms-LM and Ms-PIMs are indicated. The protein molecular
weight standards are provided on the left for comparison. (b) Equivalent
aliquots (50 000 cpm) of [14C]-lipoglycans from
each strain were immunoblotted with α-AraLAM antibody F30-5
that recognizes the branches of the arabinan domain of LAM. The major
band represented by Ms-LAM is indicated. The protein molecular weight
standards are provided on the left for comparison.
Structural Characterization of LAM Isolated
from the M. smegmatis aftB Conditional Mutant
One of the
disadvantages in generating conditional mutants by employing CESTET
is the restricted time scale where cells have to be cultured in the
absence of acetamide long enough to deplete the intracellular protein
of interest but short enough not to yield persister cells, which results
in a modest yield of cell mass. In order to further analyze the different
LAM preparations by NMR spectroscopy and improve the carbon signal
intensity due to poor cell yield, we labeled M. smegmatisΔaftB pMV306-aftB cultured
in the presence and absence of acetamide with [13C]-glucose
for 10 h, followed by lipoglycan extraction. Purified [13C]-lipoglycans were recovered from the crude extracts by hydrophobic
and gel exclusion chromatography before subjecting samples to 1H–13C HSQC analysis. On the basis of our
earlier studies with mycobacterial LAM[13] and previously published work,[20,21] we assigned
the proton and carbon resonances of the different spin systems using 1H–13C HSQC experiments. The 13C resonances at δ101.1 ppm and δ102.3 ppm correlating
to protons at δ5.11 ppm and δ4.91 ppm were assigned as
2,6-α-Manp and 6-α-Manp linkages, respectively (Figure a,b). The resonance at δ105.0 ppm, which correlated
to an anomeric proton at δ5.04 ppm, was designated as t-α-Manp. As expected, the resonances associated with the mannan
core (2,6-α-Manp, 6-α-Manp, and t-α-Manp) remained unaffected by the
disruption of AftB activity and as a result were visible in both 1H–13C HSQC spectra (Figure a,b). The resonances associated with the
arabinan domain, however, were notably more complex in the spectra
of LAM isolated from the M. smegmatisΔaftB::pMV306-aftB grown in the presence
of acetamide (Figure a) than compared to the resonances of LAM extracted from M. smegmatisΔaftB::pMV306-aftB grown in the absence of the inducer (Figure b). Several spin systems with 13C resonances at δ110.0 ppm and δ110.4 ppm were
assigned to anomeric protons at δ5.16 ppm and δ5.08 ppm,
respectively, and designated as 5-α-Araf in
different chemical environments. The 3,5-α-Araf residues corresponded to δ110.4 ppm and were assigned to protons
at δ5.09 ppm. The 2,3-α-Araf and 2,5-α-Araf linkages corresponded to δ108.4 ppm and δ108.6
ppm with protons at δ5.24 ppm and δ5.17 ppm, respectively
(Figure a). Finally,
the 13C resonance at δ103.5 ppm was designated to
δ 5.14 ppm as the t-β-Araf linkage (Figure a). Most importantly,
only 5-α-Araf and 3,5-α-Araf residues were conserved in the LAM of M. smegmatisΔaftB::pMV306-aftB depleted
of AftB, but 2,3-α-Araf, 2,5-α-Araf, and t-β-Araf linkages were absent
due to the loss of β(1 → 2) linkages (Figure a,b). The 1H–13C HSQC experiments confirmed that AftB acts as a β(1
→ 2) ArafT in the biosynthesis of LAM in M. smegmatis. The full HSQC spectra are available in the Supporting Information (Supporting Figure 1).
Further chemical characterization, such as gas chromatography analysis,
could provide accurate glycosyl composition of the truncated LAM;
however due to the nature of the conditional mutant and a modest yield
of cell mass generated, such analysis has proved to be extremely difficult
to perform.
Figure 4
Expanded region (δ 1H: 4.80–5.30, δ 13C: 100–112) of the two-dimensional 1H–13C HSQC spectra in D2O at 313 K of M. smegmatis LAM extracted from the aftB conditional mutant
in the presence (a) and absence (b) of AftB.
Expanded region (δ 1H: 4.80–5.30, δ 13C: 100–112) of the two-dimensional 1H–13C HSQC spectra in D2O at 313 K of M. smegmatis LAM extracted from the aftB conditional mutant
in the presence (a) and absence (b) of AftB.
Analysis of Toll-like Receptor 2 Activation and Cytokine Production
by Truncated LAM
Both LM and LAM display immunoregulatory
and anti-inflammatory properties that affect the host immune response.[22,23] A family of pattern recognition receptors, named TLR2 in association
with TLR1 and TLR6, detect a wide range of ligands including mycobacterial
LAM. Studies have demonstrated that the lipidic part of the molecule
is required for its activity, whereas the glycosidic moiety was shown
to contribute by directly controlling the extent of this activity.[24] Thus, we explored the capacity of truncated
LAM extracted from the conditional M. smegmatisΔaftB::pMV306-aftB mutant depleted of AftB
to induce TLR2-dependent innate immune responses. Previous studies
demonstrated that a positive relation exists between the length of
the mannan chain and the ability of the lipoglycan to activate TLR2.[24] Lipoglycans with accessible long mannan domains,
such as LM, were shown to be potent inducers of TLR2, whereas LAM
molecules were poor activators of the TLR2 signaling due to their
large arabinan domain somehow obstructing the availability of the
mannan chain.[13,25,26] Crude lipoglycan preparations extracted from M. smegmatisΔaftB::pMV306-aftB, cultured
in the presence and absence of acetamide, were subsequently subjected
to hydrophobic and size exclusion chromatography to yield pure LAM
fractions (Figure a,b).[27,28] Earlier studies have reported that some
of the LAM preparation from M. smegmatis may have
been contaminated with lipopeptides and as a result had an immune
stimulatory activity.[13,24] Therefore, we have assessed both
purified truncated and full-length LAM fractions for their activity
on HEK293 cells that stably express human TLR4, which is the receptor
for bacterial lipopolysaccharide (LPS) and lipid A.[29] Cells were incubated with LPS, which served as a positive
control, at concentrations ranging from 0.01 ng mL–1 to 1 μg mL–1 and both LAM fractions at concentrations
ranging from 0.5 ng mL–1 to 10 μg mL–1. In the presence of LPS, a dose-dependent effect was observed, whereas
HEK293-TLR4 cells stimulated with the purified full-length and truncated
LAM resulted in similar results to those of the noninduced cells (Figure a). Therefore, we
have concluded that the isolated LAM fractions were devoid of lipopeptide
contamination. Subsequently, a derivative of HEK293 cells that stably
expresses human TLR2 along with a NF-κB-inducible reporter system
were incubated with full-length and truncated LAM extracted from M. smegmatisΔaftB::pMV306-aftB grown in the presence and absence of acetamide, respectively,
at concentrations ranging from 0.5 ng mL–1 to 10
μg mL–1. The synthetic Pam3CSK4 lipopeptide was used as a positive control of TLR2 activation
at concentrations ranging from 0.01 ng mL–1 to 1
μg mL–1. As shown in Figure b, both purified LAM molecules induced NF-κB
activation in a dose-dependent fashion with the truncated LAM exhibiting
a stronger TLR2 activation than compared to the full length LAM. A
similar dose-dependent effect was observed when human monocyte/macrophage
THP-1 cells, which also stably express a NF-κB-inducible reporter
system, were incubated with full length LAM, truncated LAM, and Pam3CSK4 ligands (Figure c). As activation of TLR2 results in production
of various cytokines and ultimately regulates the adaptive immunity,
TLR2-dependent IL-8 production was measured in the supernatants of
stimulated THP-1 cells (Figure d). Cells were incubated with full length and truncated LAM
at concentrations of 2 μg mL–1 and 10 μg
mL–1 and a positive reference ligand Pam3CSK4 at concentrations of 100 ng mL–1 and 1 μg mL–1. The TLR2 dependent activation
of NF-κB and subsequently the production of IL-8 by truncated
LAM was significantly stronger than compared to the one induced by
full-length LAM (Figure d). The potency of truncated LAM to induce TLR2 response in both
HEK293 and THP-1 cells suggests that a more exposed mannan chain may
allow TLR2 to more readily recognize the lipoglycan. This is also
consistent with the previous reports.[13] In addition, we assessed if the induction of NF-κB and production
of IL-8 is a direct result of TLR2 activation by using an anti-TLR2
antibody in THP-1 cells (Figures e, 6f). Cells were preincubated
with the anti-TLR2 or isotype control antibodies (10 μg mL–1) for 30 min at 37 °C followed by incubation
with full length LAM (5 μg mL–1), truncated
LAM (5 μg mL–1), or Pam3CSK4 lipopeptide (1 μg mL–1). Both full
length and truncated LAM induced activation of NF-κB (Figure e) and as a result
production of IL-8 (Figure f) that was almost completely abolished by an anti-TLR2 antibody,
thus demonstrating signaling through the TLR2.
Figure 5
LAM purification profiles
of M. smegmatisΔaftB pMV306-aftB grown with (a) and without
(b) acetamide by gel exclusion chromatography. Eluted samples were
analyzed using SDS-PAGE and visualized by Pro-Q emerald glycoprotein
stain. The three major bands represented by Ms-LAM, Ms-LM, and Ms-PIMs
are indicated. The protein molecular weight standards are provided
on the left for comparison. The indicated fractions that contained
pure LAM lipoglycan were pooled, extensively dialyzed in water, and
dried.
Figure 6
Immune response profiles elicited by LAM extracted
from conditional aftB mutant cultured in the presence
and absence of acetamide.
(a) TLR4-dependent NF-κB activity by human HEK293-TLR4 cell
line in response to the lipoglycans. (b) TLR2-dependent NF-κB
activity by human HEK293-TLR2 cell line in response to the lipoglycans.
TLR2-dependent NF-κB (c) activation and IL-8 (d) production
by human monocyte/macrophage THP1 cell line in response to lipoglycans.
TLR2-dependent NF-κB (e) activation and IL-8 (f) production
by human THP-1 cells in response to lipoglycans were tested using
blocking antibody anti-TLR-2. Results are mean ± SD from n = 2 (a–c, e) or n = 3 (d, f) and
are from one representative of two (d, f) or three (a–c, e)
independent experiments. The ×10 means that the concentration
of cytokine detected is amplified 10-fold. *< 0.05; n.i., not induced.
LAM purification profiles
of M. smegmatisΔaftB pMV306-aftB grown with (a) and without
(b) acetamide by gel exclusion chromatography. Eluted samples were
analyzed using SDS-PAGE and visualized by Pro-Q emerald glycoprotein
stain. The three major bands represented by Ms-LAM, Ms-LM, and Ms-PIMs
are indicated. The protein molecular weight standards are provided
on the left for comparison. The indicated fractions that contained
pure LAM lipoglycan were pooled, extensively dialyzed in water, and
dried.Immune response profiles elicited by LAM extracted
from conditional aftB mutant cultured in the presence
and absence of acetamide.
(a) TLR4-dependent NF-κB activity by human HEK293-TLR4 cell
line in response to the lipoglycans. (b) TLR2-dependent NF-κB
activity by human HEK293-TLR2 cell line in response to the lipoglycans.
TLR2-dependent NF-κB (c) activation and IL-8 (d) production
by human monocyte/macrophage THP1 cell line in response to lipoglycans.
TLR2-dependent NF-κB (e) activation and IL-8 (f) production
by human THP-1 cells in response to lipoglycans were tested using
blocking antibody anti-TLR-2. Results are mean ± SD from n = 2 (a–c, e) or n = 3 (d, f) and
are from one representative of two (d, f) or three (a–c, e)
independent experiments. The ×10 means that the concentration
of cytokine detected is amplified 10-fold. *< 0.05; n.i., not induced.A substantial number of biological
activities have been associated
with phosphatidyl-myo-inositol-based glycolipids,
notably LM and LAM.[22,23,30] LM, a precursor of LAM, is composed of the conserved mannosyl-phosphate
inositol anchor and mannan core. It was demonstrated to carry a dual
modulatory function where it acts as a strong agonist for TLR2-dependent
stimulation as well as exhibits TLR2 independent inhibition of cell
activation and proinflammatory cytokine synthesis in murine primary
macrophages.[25] Further studies revealed
that the degree of LM acylation plays an important role in pro- and
anti- inflammatory properties[31,32] whereas its mannan
chain directly determines the lipoglycan activity.[24] Specifically, the activity of lipoglycans seemed to increase
with the number of Manp units composing the mannan
core. Interestingly, mycobacterial LAMs have been shown to be poor
agonists of TLR2 despite containing the LM glycosidic moiety. It is
unclear how, but the large arabinan domain in LAM perturbs the biological
activity of the mannan core. This was further confirmed by the chemical
degradation of the arabinan domain of LAM and the regain of proinflammatory
properties.[26] The data presented here are
in agreement with these findings as the truncated LAM isolated from
the conditional aftB mutant demonstrated an increase
in TLR2-dependent proinflammatory activity compared to the full-length
LAM. It was suggested that the arabinan domain may exert its inhibitory
effect by steric hindrance, which prevents interaction between TLR2
and the underlying mannan domain.[26] The
arrangement of the arabinofuranose residues in LAM is largely dependent
on the flexibility of the glycosidic linkages and puckering of the
rings. It is known that ring puckering along with the more rigid β(1
→ 2) linkages promote water mediated hydrogen bonding between
different arabinofuranose residues. A structural study using fragments
of the nonreducing termini of LAM and a murine antibody CS-35Fab has
suggested that such hydrogen bonding between the arabinofuranose rings
might contribute to the stabilization and orientation of the arabinan
component of LAM.[33] Therefore, we hypothesize
that removal of the terminal β(1 → 2) linkages can lead
to a decrease in the propensity of hydrogen bonding and subsequently
to a less organized and structurally compact arabinan domain as well
as offer additional flexibility. This in turn can result in a more
exposed “bioactive” mannan core. Further investigation
is required to fully understand arabinan’s role of LAM in relation
to TLR2 activation.[26]
Methods
Plasmid Construction
The 1938 bp
coding region aftB (MSMEG_6400) was amplified by
PCR from M. smegmatis mc2155 genomic DNA
using the primer pair (restriction
sites underlined): 5′-GAT CGA TCG GAT CCG TGC GCA TCA GCC TGT
GGC-3′ and 5′-GAT CGA TCA TCG ATC TAC GGT CCC GTT GCC
GGC-3′. A single copy integrating plasmid pMV306-aftB was generated by ligating a 2.6 kb inducible acetamide promoter
digested with XbaI-BamHI and a 1.9 kb aftB digested with BamHI-ClaI into pMV306 digested with
XbaI-ClaI resulting in a pMV306 construct containing aftB gene cloned downstream of the acetamide promoter. The merodiploid
strain was generated by electroporation of M. smegmatis with pMV306-aftB and selecting for kanamycin resistant
colonies.
Generation of ΔaftB Conditional Mutant
in M. smegmatis
Approximately 1 kb upstream
and downstream, flanking sequences of MSMEG_6400 (aftB) were PCR amplified from M. smegmatis mc2155 genomic DNA using the primer pairs: MS6400LL (5′-TTT TTT
TTC CAT AAA TTG GGA GTT ACA CCA GCA GCT ACC-3′) and MS6400LR
(5′-TTT TTT TTC CAT TTC TTG GAC CAG CAC ACC ATC ATC C-3′)
as well as MS6400RL (5′-TTT TTT TTC CAT AGA TTG GAT GGG CAT
GCT GGG CAT GAA CG-3′) and MSMEG6400RR (5′-TTT TTT TTC
CAT CTT TTG GCA CCG AGA TGC CCG AGT TGT AG-3′). Following restriction
digestion of the primer incorporated Van91I sites, the PCR fragments
were cloned into Van91I-digested p0004S to yield the plasmid pΔMSMEG6400.
The resultant plasmid was then packaged into the temperature sensitive
phage phAE159 as described previously[34] to yield the knockout phage phΔMSMEG6400. Specialized transduction
was performed as described earlier,[34] except
that the host strain was the merodiploid strain and half of the transduction
mix was spread on TSB agar plates containing kanamycin, hygromycin,
and 0.2% (w/v) acetamide while the other half was spread on plates
lacking acetamide. Deletion of the aftB gene was
confirmed using Southern blot analysis.
Conditional Depletion of
AftB
Strains to be tested
were grown in either TSB or minimal medium supplemented with 0.05%
(v/v) Tween-80 and 0.2% (w/v) acetamide to an OD 600 nm of 0.5. Cells
were washed twice with media to remove traces of acetamide and resuspended
in the original volume of appropriate media. Culture was used as a
20% inoculum in minimal media and grown for 12 h to deplete intracellular
AftB. The depleted subculture served as inoculum (5%) for cultures
with or without 0.2% (w/v) acetamide. Aliquots were taken and labeled
with either [1, 2-14C]-glucose 1 μCi mL–1 or [13C6]-glucose for 10 h. Cells were harvested,
washed with phosphate buffered saline, and dried.
Cell Stimulation
Assays
For stimulation assays, HEK293
and THP-1 cells were plated at 50 000 cells per well. Cells
were stimulated with LAM at 0.5 ng mL–1 to 10 μg
mL–1 in a final volume of 200 μL. Nonstimulated
cells and cells stimulated with Pam3CSK4 (InvivoGen) or LPS (InvivoGen)
served as negative and positive controls, respectively. Alkaline phosphatase
activity was measured after 16–18 h by mixing 20 μL of
the culture supernatant and 180 μL of Quanti-BlueTM, reading
absorbance at OD 630 nm. To investigate TLR2 dependence, THP-1 cells
were preincubated for 30 min at 37 °C with 5 or 10 μg mL–1 of anti-TLR2 monoclonal antibody (clone T2.5, InvivoGen,
mab-mtlr2, lot # MT2-37-01) or isotype control (IgG1, eBioscience,
16-4714–85, lot # 4295108).
Cytokine ELISA
Culture supernatants from THP-1 cells
were harvested and assayed for IL-8 cytokine production using commercially
available ELISA kit and according to the manufacturer’s instructions
(Ready Set-Go ELISA kits, eBioscience).
Authors: A Telenti; W J Philipp; S Sreevatsan; C Bernasconi; K E Stockbauer; B Wieles; J M Musser; W R Jacobs Journal: Nat Med Date: 1997-05 Impact factor: 53.440
Authors: B J Appelmelk; J den Dunnen; N N Driessen; R Ummels; M Pak; J Nigou; G Larrouy-Maumus; S S Gurcha; F Movahedzadeh; J Geurtsen; E J Brown; M M Eysink Smeets; G S Besra; P T J Willemsen; T L Lowary; Y van Kooyk; J J Maaskant; N G Stoker; P van der Ley; G Puzo; C M J E Vandenbroucke-Grauls; C W Wieland; T van der Poll; T B H Geijtenbeek; A M van der Sar; W Bitter Journal: Cell Microbiol Date: 2007-12-05 Impact factor: 3.715
Authors: Shiva Kumar Angala; Juan Manuel Belardinelli; Emilie Huc-Claustre; William H Wheat; Mary Jackson Journal: Crit Rev Biochem Mol Biol Date: 2014-06-10 Impact factor: 8.250
Authors: Mathias Seidel; Luke J Alderwick; Helen L Birch; Hermann Sahm; Lothar Eggeling; Gurdyal S Besra Journal: J Biol Chem Date: 2007-03-26 Impact factor: 5.157
Authors: Eun-Ik Koh; Peter O Oluoch; Nadine Ruecker; Megan K Proulx; Vijay Soni; Kenan C Murphy; Kadamba Papavinasasundaram; Charlotte J Reames; Carolina Trujillo; Anisha Zaveri; Matthew D Zimmerman; Roshanak Aslebagh; Richard E Baker; Scott A Shaffer; Kristine M Guinn; Michael Fitzgerald; Véronique Dartois; Sabine Ehrt; Deborah T Hung; Thomas R Ioerger; Eric J Rubin; Kyu Y Rhee; Dirk Schnappinger; Christopher M Sassetti Journal: Proc Natl Acad Sci U S A Date: 2022-04-05 Impact factor: 12.779
Authors: Alok Choudhary; Deendayal Patel; William Honnen; Zhong Lai; Raja Sekhar Prattipati; Ruixiang Blake Zheng; Ying-Chao Hsueh; Maria Laura Gennaro; Alfred Lardizabal; Blanca I Restrepo; Moncerrato Garcia-Viveros; Maju Joe; Yu Bai; Ke Shen; Kamar Sahloul; John S Spencer; Delphi Chatterjee; Tobias Broger; Todd L Lowary; Abraham Pinter Journal: J Immunol Date: 2018-04-02 Impact factor: 5.422
Authors: Alexander M Justen; Heather L Hodges; Lili M Kim; Patric W Sadecki; Sara Porfirio; Eveline Ultee; Ian Black; Grace S Chung; Ariane Briegel; Parastoo Azadi; Laura L Kiessling Journal: Sci Adv Date: 2020-09-16 Impact factor: 14.136
Authors: Monika Jankute; Luke J Alderwick; Alice R Moorey; Maju Joe; Sudagar S Gurcha; Lothar Eggeling; Todd L Lowary; Anne Dell; Poh-Choo Pang; Tiandi Yang; Stuart Haslam; Gurdyal S Besra Journal: Cell Surf Date: 2018-06